By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Epigenomics AG 

Kleine Präsidentenstraße 1

Berlin    D-10178  Germany
Phone: 49-30-24-34-5-0 Fax: +49-30-24-34-55-55



Company News
Epigenomics AG Converts To Registered Shares 9/19/2014 12:32:07 PM
Epigenomics AG Announces H1 2014 And Q2 2014 Financial Results And Reports On Operational Highlights 8/12/2014 12:48:05 PM
Epigenomics AG Provides Update On Regulatory Status And Information On Additional Clinical Study For Epi proColon® In The U.S. 7/1/2014 10:38:02 AM
Epigenomics AG Announces Publication Of Results Of Two U.S. Clinical Studies With Its Blood-based Epi proColon® CRC Screening Test 6/24/2014 8:59:05 AM
FDA Issues Response Letter For Epigenomics AG's Colorectal Cancer Screening Blood Test Epi Procolon® Requesting Further Data Pre-Approval 6/2/2014 2:52:09 PM
Epigenomics AG Begins Trading On OTCQX® 1/10/2014 9:31:12 AM
Epigenomics AG Signs Licensing And Supply Agreement With Wuhan Kindstar Diagnostics For Epi Prolung In China 1/9/2014 10:41:28 AM
Epigenomics AG Announces FDA Advisory Committee Meeting To Review Epi proColon® 11/27/2013 1:28:30 PM
Epigenomics AG’ Methylated SHOX2 Biomarker Shows Promising Results For Therapy Monitoring Of Lung Cancer Patients 11/20/2013 1:46:47 PM
Epigenomics AG and BioChain Enter Into Broad Strategic Collaboration in China and Investment Into Epigenomics 10/28/2013 9:36:00 AM